Cite
HARVARD Citation
Congdon, E. et al. (2016). Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy. Molecular neurodegeneration. 11 (1), pp. 1-24. [Online].